<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>03760369291187</udiDi>
    <basicUdiDi>B-03760369291187</basicUdiDi>
    <tradeName>03760369291187</tradeName>
    <deviceName>RedQal Group</deviceName>
    <manufacturerName>ETABLISSEMENT FRANCAIS DU SANG</manufacturerName>
    <manufacturerSrn>FR-MF-000013221</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste A</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0103030999</emdnCode>
    <emdnDescription>COMBINED ABO TYPING + RHESUS TYPING TEST - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>190045</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-05T19:19:47.047Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760369291132</udiDi>
    <basicUdiDi>B-03760369291132</basicUdiDi>
    <tradeName>CQI ABO-D - Rh.K - Contrôle Qualité Interne pour la détermination des groupes   sanguins dans les systèmes ABO Rhésus Kell (CB Grifols)</tradeName>
    <deviceName>RedQal Group G</deviceName>
    <manufacturerName>ETABLISSEMENT FRANCAIS DU SANG</manufacturerName>
    <manufacturerSrn>FR-MF-000013221</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste A</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0103030999</emdnCode>
    <emdnDescription>COMBINED ABO TYPING + RHESUS TYPING TEST - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>242623</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-05T19:19:42.375Z</lastUpdated>
  </row>
</eudamedExport>